Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Telephone
61.8.9389.3180
Address
Suite 5 CPC 145 Stirling Highway Nedlends, Western Australia (WA) 6009
Description
Melodiol Global Health Ltd. engages in the developing, register and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following geographical segments: Europe includes Creso Pharma Switzerland GmbH, Canada includes the operating companies; Mernova Medicinal Inc, Halucenex Life Sciences Inc., Creso Impactive Ltd, United States of America, and Creso Pharma Limited in Australia. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 4.2
Trade Value (12mth)
AU$13,655.00
1 week
0%
1 month
0%
YTD
-99.83%
1 year
-99.97%
All time high
990.00
EPS 3 yr Growth
N/A
EBITDA Margin
0.00%
Operating Cashflow
-$9m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
N/A
Quick Ratio
0.00
Shares on Issue (Fully Dilluted)
109m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
06 September 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
04 September 24 |
Notification of cessation of securities - ME1
×
Notification of cessation of securities - ME1 |
28 August 24 |
Suspension from Quotation
×
Suspension from Quotation |
26 August 24 |
Cleansing Statement
×
Cleansing Statement |
23 August 24 |
Notification of cessation of securities - ME1
×
Notification of cessation of securities - ME1 |
23 August 24 |
Application for quotation of securities - ME1
×
Application for quotation of securities - ME1 |
15 August 24 |
Application for quotation of securities - ME1
×
Application for quotation of securities - ME1 |
15 August 24 |
Application for quotation of securities - ME1
×
Application for quotation of securities - ME1 |
15 August 24 |
Cleansing Statement
×
Cleansing Statement |
15 August 24 |
Mernova Revenue Update
×
Mernova Revenue Update |
15 August 24 |
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)
×
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU) |
15 August 24 |
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)
×
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU) |
15 August 24 |
Melodiol Global Health Limited - Cleansing Statement (ME1-AU)
×
Melodiol Global Health Limited - Cleansing Statement (ME1-AU) |
15 August 24 |
Melodiol Global Health Limited - Mernova Revenue Update (ME1-AU)
×
Melodiol Global Health Limited - Mernova Revenue Update (ME1-AU) |
13 August 24 |
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)
×
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU) |
13 August 24 |
Melodiol Global Health Limited - Cleansing Statement (ME1-AU)
×
Melodiol Global Health Limited - Cleansing Statement (ME1-AU) |
02 August 24 |
Application for quotation of securities - ME1
×
Application for quotation of securities - ME1 |
02 August 24 |
Cleansing Statement
×
Cleansing Statement |
02 August 24 |
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU)
×
Melodiol Global Health Limited - Application for quotation of securities - ME1 (ME1-AU) |
02 August 24 |
Melodiol Global Health Limited - Cleansing Statement (ME1-AU)
×
Melodiol Global Health Limited - Cleansing Statement (ME1-AU) |
31 July 24 |
Melodiol Global Health Limited - Notification of cessation of securities - ME1 (ME1-AU)
×
Melodiol Global Health Limited - Notification of cessation of securities - ME1 (ME1-AU) |
31 July 24 |
Melodiol Global Health Limited - Quarterly Activities/Appendix 4C Cash Flow Report (ME1-AU)
×
Melodiol Global Health Limited - Quarterly Activities/Appendix 4C Cash Flow Report (ME1-AU) |
30 July 24 |
Melodiol Global Health Limited - Corporate Update (ME1-AU)
×
Melodiol Global Health Limited - Corporate Update (ME1-AU) |
30 July 24 |
Melodiol Global Health Limited - Proposed issue of securities - ME1 (ME1-AU)
×
Melodiol Global Health Limited - Proposed issue of securities - ME1 (ME1-AU) |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.